Acute Treatment of Migraine: Expert Consensus Statements from the United Arab Emirates (UAE)

Abstract Introduction Migraine, characterized by recurrent headaches and often accompanied by other symptoms like nausea, vomiting, and sensitivity to light and sound, significantly impacts patients’ quality of life (QoL) and daily functioning. The global burden of migraines is reflected not only in...

Full description

Bibliographic Details
Main Authors: Taoufik Alsaadi, Deeb M. Kayed, Abubaker Al-Madani, Ali Mohamed Hassan, Derk Krieger, Naji Riachi, Pournamy Sarathchandran, Suhail Al-Rukn
Format: Article
Language:English
Published: Adis, Springer Healthcare 2024-01-01
Series:Neurology and Therapy
Subjects:
Online Access:https://doi.org/10.1007/s40120-023-00576-4
_version_ 1797246939958345728
author Taoufik Alsaadi
Deeb M. Kayed
Abubaker Al-Madani
Ali Mohamed Hassan
Derk Krieger
Naji Riachi
Pournamy Sarathchandran
Suhail Al-Rukn
author_facet Taoufik Alsaadi
Deeb M. Kayed
Abubaker Al-Madani
Ali Mohamed Hassan
Derk Krieger
Naji Riachi
Pournamy Sarathchandran
Suhail Al-Rukn
author_sort Taoufik Alsaadi
collection DOAJ
description Abstract Introduction Migraine, characterized by recurrent headaches and often accompanied by other symptoms like nausea, vomiting, and sensitivity to light and sound, significantly impacts patients’ quality of life (QoL) and daily functioning. The global burden of migraines is reflected not only in terms of reduced QoL but also in the form of increased healthcare costs and missed work or school days. While UAE (United Arab Emirates)-specific consensus-based recommendations for the effective use of preventive calcitonin gene-related peptide (CGRP)-based migraine therapies have been published previously, an absence of such regional guidance on the management of acute migraine represents a gap that needs to be urgently addressed. Methods A task force of eight neurologists from the UAE with expertise in migraine management conducted a comprehensive literature search and developed a set of expert statements on the management of acute migraine that were specific to the UAE context. To ensure diverse perspectives are considered, a Delphi panel comprising 16 neurologists plus the task force members was set up. Consensus was achieved using a modified Delphi survey method. Consensus was predefined as a median rating of 7 or higher without discordance (if > 25% of the Delphi panelists rate an expert statement as 3 or lower on the Likert scale). Expert statements achieving consensus were adopted. Results The Modified Delphi method was used successfully to achieve consensus on all nine expert statements drafted by the task force. These consensus statements aim to provide a comprehensive guide for UAE healthcare professionals in treating acute migraine. The statements cover all aspects of acute migraine treatment, including what goals to set, the timing of treatment, treatment strategy to use in case of inadequate response to triptans, safety aspects of combining gepants for acute attacks with preventive CGRP-based therapies, special population (pregnant and pediatric patients) considerations, and the management of the most bothersome symptoms (MBS). Conclusions Adopting these consensus statements on the treatment of acute migraine can help enhance patient care, improve outcomes, and standardize treatment practices in the UAE. The collaborative effort of experts with diverse experiences in developing these consensus statements will strengthen the credibility and applicability of these statements to various healthcare settings in the country.
first_indexed 2024-04-24T19:50:46Z
format Article
id doaj.art-820ee0eaa7554269adf8b434ef0e079b
institution Directory Open Access Journal
issn 2193-8253
2193-6536
language English
last_indexed 2024-04-24T19:50:46Z
publishDate 2024-01-01
publisher Adis, Springer Healthcare
record_format Article
series Neurology and Therapy
spelling doaj.art-820ee0eaa7554269adf8b434ef0e079b2024-03-24T12:37:51ZengAdis, Springer HealthcareNeurology and Therapy2193-82532193-65362024-01-0113225728110.1007/s40120-023-00576-4Acute Treatment of Migraine: Expert Consensus Statements from the United Arab Emirates (UAE)Taoufik Alsaadi0Deeb M. Kayed1Abubaker Al-Madani2Ali Mohamed Hassan3Derk Krieger4Naji Riachi5Pournamy Sarathchandran6Suhail Al-Rukn7Department of Neurology, American Center for Psychiatry and NeurologyNeurology Department, Mediclinic City HospitalNeurology Department, Rashid HospitalNeurology Department, Rashid HospitalNMC Royal at DIP, United Medical Center, Fakeeh University HospitalSheikh Shakhbout Medical City, Khalifa University College of Medicine and Health SciencesAl Qassimi Hospital, Ministry of HealthNeurology Department, Rashid HospitalAbstract Introduction Migraine, characterized by recurrent headaches and often accompanied by other symptoms like nausea, vomiting, and sensitivity to light and sound, significantly impacts patients’ quality of life (QoL) and daily functioning. The global burden of migraines is reflected not only in terms of reduced QoL but also in the form of increased healthcare costs and missed work or school days. While UAE (United Arab Emirates)-specific consensus-based recommendations for the effective use of preventive calcitonin gene-related peptide (CGRP)-based migraine therapies have been published previously, an absence of such regional guidance on the management of acute migraine represents a gap that needs to be urgently addressed. Methods A task force of eight neurologists from the UAE with expertise in migraine management conducted a comprehensive literature search and developed a set of expert statements on the management of acute migraine that were specific to the UAE context. To ensure diverse perspectives are considered, a Delphi panel comprising 16 neurologists plus the task force members was set up. Consensus was achieved using a modified Delphi survey method. Consensus was predefined as a median rating of 7 or higher without discordance (if > 25% of the Delphi panelists rate an expert statement as 3 or lower on the Likert scale). Expert statements achieving consensus were adopted. Results The Modified Delphi method was used successfully to achieve consensus on all nine expert statements drafted by the task force. These consensus statements aim to provide a comprehensive guide for UAE healthcare professionals in treating acute migraine. The statements cover all aspects of acute migraine treatment, including what goals to set, the timing of treatment, treatment strategy to use in case of inadequate response to triptans, safety aspects of combining gepants for acute attacks with preventive CGRP-based therapies, special population (pregnant and pediatric patients) considerations, and the management of the most bothersome symptoms (MBS). Conclusions Adopting these consensus statements on the treatment of acute migraine can help enhance patient care, improve outcomes, and standardize treatment practices in the UAE. The collaborative effort of experts with diverse experiences in developing these consensus statements will strengthen the credibility and applicability of these statements to various healthcare settings in the country.https://doi.org/10.1007/s40120-023-00576-4Acute migraineConsensus statementsRecommendationsCGRP-based therapyGepants
spellingShingle Taoufik Alsaadi
Deeb M. Kayed
Abubaker Al-Madani
Ali Mohamed Hassan
Derk Krieger
Naji Riachi
Pournamy Sarathchandran
Suhail Al-Rukn
Acute Treatment of Migraine: Expert Consensus Statements from the United Arab Emirates (UAE)
Neurology and Therapy
Acute migraine
Consensus statements
Recommendations
CGRP-based therapy
Gepants
title Acute Treatment of Migraine: Expert Consensus Statements from the United Arab Emirates (UAE)
title_full Acute Treatment of Migraine: Expert Consensus Statements from the United Arab Emirates (UAE)
title_fullStr Acute Treatment of Migraine: Expert Consensus Statements from the United Arab Emirates (UAE)
title_full_unstemmed Acute Treatment of Migraine: Expert Consensus Statements from the United Arab Emirates (UAE)
title_short Acute Treatment of Migraine: Expert Consensus Statements from the United Arab Emirates (UAE)
title_sort acute treatment of migraine expert consensus statements from the united arab emirates uae
topic Acute migraine
Consensus statements
Recommendations
CGRP-based therapy
Gepants
url https://doi.org/10.1007/s40120-023-00576-4
work_keys_str_mv AT taoufikalsaadi acutetreatmentofmigraineexpertconsensusstatementsfromtheunitedarabemiratesuae
AT deebmkayed acutetreatmentofmigraineexpertconsensusstatementsfromtheunitedarabemiratesuae
AT abubakeralmadani acutetreatmentofmigraineexpertconsensusstatementsfromtheunitedarabemiratesuae
AT alimohamedhassan acutetreatmentofmigraineexpertconsensusstatementsfromtheunitedarabemiratesuae
AT derkkrieger acutetreatmentofmigraineexpertconsensusstatementsfromtheunitedarabemiratesuae
AT najiriachi acutetreatmentofmigraineexpertconsensusstatementsfromtheunitedarabemiratesuae
AT pournamysarathchandran acutetreatmentofmigraineexpertconsensusstatementsfromtheunitedarabemiratesuae
AT suhailalrukn acutetreatmentofmigraineexpertconsensusstatementsfromtheunitedarabemiratesuae